Pharmaceutical Business Review | UPDATE 1-Actavis, Adamas win FDA approval for Alzheimer's drug Reuters (Adds details, background, share). Dec 24 (Reuters) - The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis Plc and Adamas Pharmaceuticals Inc. Adamas shares were up nearly 17 ... Actavis, Adamas Pharma Win FDA Approval For Alzheimer's Drug Namzaric Actavis Alzheimers Drug Approved; Bystolic Gets CRL Actavis, Adamas win FDA approval for Alzheimer's drug |